| 1 |
TGFbeta1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis Original Article |
Hepatitis Monthly 22(1):- |
2022 |
| 2 |
Capparis spinosa improves non-alcoholic steatohepatitis through down-regulating SREBP-1c and a PPARalpha-independent pathway in high-fat diet-fed rats Original Article |
BMC Research Notes 15(1),315 |
2022 |
| 3 |
Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis Original Article |
Journal of Diabetes and Metabolic Disorders 21(2):1531-1538 |
2022 |
| 4 |
Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis Original Article |
Endocrine Metabolic and Immune Disorders Drug Targets 22(12):1191-1200 |
2022 |
| 5 |
Endothelin-1 Stimulates PAI-1 Protein Expression via Dual Transactivation Pathway Dependent ROCK and Phosphorylation of Smad2L Original Article |
Cell Journal 24(8):465-472 |
2022 |
| 6 |
Mesenchymal stem cells derived from the kidney can ameliorate diabetic nephropathy through the TGF-beta/Smad signaling pathway Original Article |
Environmental Science and Pollution Research 29(35):53212-53224 |
2022 |
| 7 |
Methylation-mediated silencing of miR-125a-5p facilitates breast cancer progression by inducing autophagy Original Article |
Molecular Biology Reports 49(7):6325-6339 |
2022 |
| 8 |
Endothelin-1 dependent expression of GAG genes involves NOX and p38 mediated Smad linker region phosphorylation Original Article |
Clinical and Experimental Pharmacology and Physiology 49(7):710-718 |
2022 |
| 9 |
Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-beta receptor Original Article |
Molecular and Cellular Biochemistry 477(4):981-988 |
2022 |
| 10 |
Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study Original Article |
Molecular Biology Reports 49(4):2839-2845 |
2022 |